Evaluating the Toxocara cati extract as a therapeutic agent for allergic airway inflammation.
Amin BakhshaniSima Parande ShirvanSoheil SadrMohsen MalekiAlireza HaghparastHassan BorjiPublished in: Immunity, inflammation and disease (2024)
These preclinical findings suggest that in experimental models, T. cati somatic extract exhibits promising potential as a therapeutic agent for mitigating allergic airway inflammation. Its observed effects on immune response modulation and reduction of inflammatory cell infiltration warrant further investigation in clinical studies to assess its efficacy and safety in human patients.
Keyphrases
- immune response
- oxidative stress
- end stage renal disease
- endothelial cells
- cell therapy
- newly diagnosed
- ejection fraction
- chronic kidney disease
- single cell
- prognostic factors
- anti inflammatory
- stem cells
- allergic rhinitis
- gene expression
- toll like receptor
- induced pluripotent stem cells
- mesenchymal stem cells
- human health